Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
Oncotelic Therapeutics (OTLC) Financial Statements
75 Followers
Oncotelic Therapeutics Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 70.00K | $ 36.99K | - | - | $ 0.00 |
| Gross Profit | $ 70.00K | $ 36.99K | - | - | - |
| EBIT | $ 226.49K | $ -6.60M | $ 264.12K | $ -4.49M | $ -252.61K |
| EBITDA | $ -25.30K | - | $ 430.55K | $ -4.07M | $ -252.61K |
| Net Income Common Stockholders | $ 115.31K | $ -6.76M | $ -138.54K | $ -5.29M | $ -777.93K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 268.02K | $ 181.87K | $ 190.44K | $ 241.45K | $ 253.88K |
| Total Assets | $ 30.10M | $ 30.01M | $ 36.05M | $ 36.12M | $ 40.24M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 11.26M | $ 10.08M |
| Net Debt | $ -268.02K | $ -181.87K | $ -190.44K | $ 11.02M | $ 9.83M |
| Total Liabilities | $ 6.18M | $ 5.61M | $ 5.74M | $ 16.92M | $ 16.21M |
| Stockholders Equity | $ 12.55M | $ 12.32M | $ 18.75M | $ 19.41M | $ 24.19M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -200.00K | - | $ -251.02K | $ -80.68K | $ -206.08K |
| Operating Cash Flow | $ -200.00K | - | $ -251.02K | $ -80.68K | $ -206.08K |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | $ 335.00K | - | $ 200.00K | $ 68.25K | $ 60.19K |
Oncotelic Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.